Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children

Ann Surg. 2000 Feb;231(2):246-52. doi: 10.1097/00000658-200002000-00014.

Abstract

Objective: To determine the effect of insulinlike growth factor I (IGF-I) in combination with its principal binding protein (IGFBP-3) on the hepatic acute phase response in severely burned children.

Summary background data: The hepatic acute phase response is a cascade of events initiated to restore homeostasis after trauma. A prolonged response, however, may contribute to multiple organ failure, hypermetabolism, complications, and death.

Methods: Twenty-two children with a mean total body surface area (TBSA) burn of 57 +/- 3% were given a continuous infusion of 1 to 4 mg/kg/day IGF-I/BP-3 for 5 days after wound excision and grafting. Eight children with a TBSA burn of 54 +/- 4% were given saline as controls. Before and 5 days after excision and grafting, blood samples were taken for serum hepatic constitutive protein, acute phase protein, and proinflammatory cytokine analysis.

Results: Serum IGF-I levels in burned children given the IGF-I/BP-3 complex increased from 113 +/- 15 to 458 +/- 40 ng/mL and IGFBP-3 levels increased from 1.8 +/- 0.2 to 3.1 +/- 0.3 ng/mL. Levels of serum constitutive hepatic proteins (prealbumin, retinol-binding protein, and transferrin) increased with IGF-I/BP-3, whereas levels of type I acute phase proteins (C-reactive protein, alpha1-acid glycoprotein, and complement C-3) decreased when compared with controls. The complex had no effect on type II acute phase proteins. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) levels decreased with IGF-I/BP-3 compared with controls, with no effect on interleukin-6.

Conclusion: Severely burned children receiving IGF-I/BP-3 showed a decrease in IL-1beta and TNF-alpha followed by a decrease in type I acute phase proteins that was associated with a concomitant increase in constitutive hepatic proteins. Attenuating the proinflammatory acute phase with IGF-1/BP-3 response may prevent multiple organ failure and improve clinical outcomes after thermal injury without any detectable adverse side effects.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute-Phase Reaction / blood
  • Acute-Phase Reaction / etiology
  • Acute-Phase Reaction / prevention & control*
  • Burns / blood
  • Burns / complications*
  • Child
  • Female
  • Humans
  • Infusions, Intravenous
  • Insulin-Like Growth Factor Binding Protein 3 / therapeutic use*
  • Insulin-Like Growth Factor I / therapeutic use*
  • Liver / physiopathology
  • Male
  • Multiple Organ Failure / prevention & control
  • Recombinant Proteins / therapeutic use

Substances

  • Insulin-Like Growth Factor Binding Protein 3
  • Recombinant Proteins
  • Insulin-Like Growth Factor I